Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Net Margin (2020 - 2025)

LifeStance Health (LFST) has disclosed Net Margin for 6 consecutive years, with 3.05% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 524.0% to 3.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.68%, a 527.0% increase, with the full-year FY2025 number at 0.68%, up 527.0% from a year prior.
  • Net Margin was 3.05% for Q4 2025 at LifeStance Health, up from 0.3% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 3.05% in Q4 2025 to a low of 69.29% in Q3 2021.
  • A 5-year average of 18.06% and a median of 16.71% in 2022 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -6606bps in 2021, then surged 5189bps in 2022.
  • LifeStance Health's Net Margin stood at 28.66% in 2021, then grew by 29bps to 20.34% in 2022, then rose by 21bps to 16.02% in 2023, then surged by 86bps to 2.19% in 2024, then soared by 240bps to 3.05% in 2025.
  • Per Business Quant, the three most recent readings for LFST's Net Margin are 3.05% (Q4 2025), 0.3% (Q3 2025), and 1.1% (Q2 2025).